A blocking peptide containing 17 amino acids near the amino terminus of human TCF3.
Points forts
Source
Synthetic
(Accession #: NP_003191) The TCF-3/E2A Blocking Peptide has been validated for the following applications: Antibody Competition.
Caractéristiques techniques
| Marque | Novus Biologicals |
|---|
| Réf. B-LABO | BL-RE-044487 |
|---|
| Réf. fabricant | 18287415 |
|---|
| Gene ID (Entrez) | 6929 |
|---|
| Espèces | Human |
|---|
| Contenu et stockage | Store at -20 C. Avoid freeze-thaw cycles. |
|---|
| Formule | PBS pH 7.2 (10 mM NaH2PO4, 10 mM Na2HPO4, 130 mM NaCl) containing 0.1% bovine serum albumin. |
|---|
| À utiliser avec (application) | This Peptide is Useful as a Blocking Peptide for NBP1-77119. For Further Blocking Peptide Related Protocol, Click Here . |
|---|
| Alias de gène | BHLHB21, bHLHb21TCF-3, Class B basic helix-loop-helix protein 21, E2A immunoglobulin enhancer-binding factor E12/E47, E2AKappa-E2-binding factor, Immunoglobulin enhancer-binding factor E12/E47, Immunoglobulin transcription factor 1, ITF1Transcription factor ITF-1, MGC129647, MGC129648, Transcription factor 3, transcription factor 3 (E2A immunoglobulin enhancer binding factors E12/E47), transcription factor E2-alpha, VDIR, VDR interacting repressor |
|---|
| Symbole de gène(s) | TCF3 |
|---|
| Type de produit | TCF-3/E2A |
|---|
| Quantité | 0.05 mg |
|---|
| État réglementaire | RUO - research use only |
|---|
| Source | Synthetic |
|---|
| Consigne | 17 amino acids near the amino terminus of human TCF3 |
|---|
Une question, une configuration particulière ?
Contactez-nous pour un devis.
